Home> News> Unique video first data wave in AML: Aggregated data from 5 studies showing the added value of increasing the number of patients analyzed

Unique video first data wave in AML: Aggregated data from 5 studies showing the added value of increasing the number of patients analyzed

July 10, 2019 11:43 - x 00, 0 - 00:00

First results produced by the HARMONY Big Data Platform using over 3.000 AML cases from five studies are visualized in a unique video. This video showcases preliminary scientific results in the HARMONY/AML Big Data Research. Moreover the content of this video will bring across how making use of Big Data tools can enhance hematology research and ultimately benefit patients.

The HARMONY video shows part of the work being executed within the HARMONY Research Project AML, titled: Use of Big Data to revise treatment strategies in Acute Myeloid Leukemia. This project evaluates gene–gene interactions in patients with AML, which may influence treatment outcomes. In addition the project teams will develop a proof-of-concept study to establish the legal and ethical framework. Project partners are: Charité University Medicine, VU University Medical Center Amsterdam, University of Ulm, Novartis, Klinikum der Universität München.

HARMONY Research Projects address specific questions for Hematologic Malignancies (HM). Relevant outcomes for patients are defined for each HM. The HARMONY Research Projects are focusing on those particular outcomes that will expand our knowledge of HMs and therapeutic approaches. Read all summaries of the current projects >

HARMONY mid term achievements and Research Projects were presented at the 24th Annual Congress of the European Hematology Association. Check the highlights of the HARMONY Congress participation >

Receive the latest news. Click here to subscribe!